Park Medi World IPO listing date today. Here's what GMP, experts signal

Park Medi World IPO listing: Shares of Park Medi World will be listed on BSE and NSE today. The grey market premium is 5.5, indicating a potential listing price of 167.5, while the overall subscription stood at 8.52 times.

Saloni Goel
Updated17 Dec 2025, 06:22 AM IST
Park Medi World IPO GMP today signals that its shares could list at  <span class='webrupee'>₹</span>167.5, a premium of 3.40% above the issue price.
Park Medi World IPO GMP today signals that its shares could list at ₹167.5, a premium of 3.40% above the issue price.(Photo Courtesy: Company Website)

Park Medi World IPO listing: The shares of Park Medi World Ltd, which operates a hospital chain under the Park brand, are set to be listed in the Indian stock market today following the successful completion of its initial public offering (IPO) last week. Park Medi World IPO listing date is today, December 16.

Park Medi World IPO was open for subscription from December 10 to December 12. The allotment for Park Medi World IPO was finalised on December 15. The company's shares will be listed on theBSE and NSE today at 10 am.

Ahead of Park Medi World IPO listing, the grey market premium (GMP) for the offer remained tepid.

Also Read | upGrad begins IPO preparations for a $350–400 million listing in 2027

Park Medi World IPO GMP

Park Medi World IPO GMP today is 5.5. This means that shares of Park Medi World are trading 5.5 above the issue price of 162. The highest GMP for Park Medi World IPO stood at 33 at one point in time, while the lowest GMP was nil.

Park Medi World IPO Listing Price

Park Medi World IPO GMP today signals that its shares could list at 167.5, a premium of 3.40% above the issue price. This coincides with analysts' view of Park Medi World shares listing at a mild premium.

Arun Kejriwal, Founder of Kejriwal Research and Investment Services, said Park Medi World IPO received a tepid response from primary market investors, which is expected to continue on the listing date. The issue may list at around the upper price band of 162 per share, he said.

Also Read | KSH International IPO off to a slow start, subscribed 15%; GMP remains nil

Meanwhile, Shivani Nyati, Head of Wealth at Swastika Investmart, said the public issue has received a strong response from both institutional and retail investors, with overall subscription standing at approximately 8.52x. Additionally, the grey market premium is trading at around 2–3%, reflecting positive pre-listing sentiment and expectations of a stable to moderately positive listing on the stock exchanges, she said.

"Park Medi World is a prominent player in the Indian healthcare and wellness sector, with a strong focus on delivering affordable healthcare services and medical technologies. The company has rapidly expanded its presence across Tier-2 and Tier-3 cities, where it has established itself as a trusted provider of medical facilities and healthcare products. Over the past three years, Park Medi World has reported robust revenue growth, supported by an expanding network and rising demand for healthcare services," Niyati noted.

Commenting on the post listing strategy, Kejriwal opined that those who received company shares through the allotment process are advised to exit at the higher levels, as both the secondary market and the grey market are showcasing par listing for the public issue.

Park Medi World IPO Details

Park Media World IPO was subscribed 8.52 times at the end of its bidding process on Friday, December 12. The issue received bids for 33,88,29,652 shares as against 4,18,18,182 shares on offer, as per BSE data.

Also Read | Park Medi World IPO: GMP, subscription status, other details. Apply or not?

The non-institutional investor (NII) segment was subscribed 15.15 times, while the qualified institutional buyer (QIB) portion saw 11.48 times subscription. The retail category was subscribed 3.16 times.

Park Media World IPO price band was fixed at 154-162 per share, with the firm looking to raise 920 crore at the upper end of the price band.

The IPO was a combination of fresh issue of shares worth 770 crore and an offer for sale of shares valued at 150 crore by promoter Ajit Gupta. Out of the fresh proceeds, the company has earmarked 380 crore for payment of debt and 60.5 crore for the development of a new hospital and the expansion of an existing hospital by its subsidiaries, Park Medicity (NCR) and Blue Heavens, respectively.

Nuvama Wealth Management, CLSA India, DAM Capital Advisors and Intensive Fiscal Services are the book-running lead managers to the IPO. KFin Technologies is the registrar to offer.

Key Takeaways
  • The IPO was subscribed 8.52 times, indicating strong interest from investors.
  • The grey market premium suggests a positive outlook for the listing.
  • Investors are advised to consider market conditions and analyst recommendations before making decisions.

Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of individual analysts or broking firms, not Mint. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

More
OPEN IN APP